Ryan D. Gentzler, MD, assistant professor, Division of Hematology/Oncology, University of Virginia Health System, discusses combination therapies in non–small cell lung cancer (NSCLC).
Ryan D. Gentzler, MD
Advertisement
Articles by Ryan D. Gentzler, MD
Ryan D. Gentzler, MD, assistant professor, Division of Hematology/Oncology, University of Virginia Health System, discusses the role of chemotherapy in patients with metastatic non–small cell lung cancer (NSCLC).
Advertisement
Latest Updated Articles
Dr. Gentzler on the Role of Chemotherapy in Metastatic NSCLCAugust 21st 2018
Dr. Gentzler on Combination Therapies in NSCLCSeptember 20th 2018
Advertisement
Advertisement
Trending on OncLive
1
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
2
Epcoritamab Significantly Improves PFS Vs Chemoimmunotherapy in R/R Large B-Cell Lymphoma
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
5